Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Gavin MacNicol Buchan has worked on the following 183 EPO patent applications which have been published in the last five years:

EP12181529

Sunscreen compositions with low eye-sting and high SPF

IPC classification:
A61Q 17/04, A61K 8/19, A61K 8/27, A61K 8/28, A61K 8/29, A61K 8/35, A61K 8/37, A61K 8/49
Applicant:
MSD Consumer Care, Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11751121

INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS

IPC classification:
A01N 43/40, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11751124

INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS

IPC classification:
C07D 213/69, C07D 213/84, C07D 213/85, C07D 401/04, C07D 413/10, C07D 417/04, A01N 43/40, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11751129

INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS

IPC classification:
A01N 43/90, A61K 31/505, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
The patent has been granted
EP11875249

FUSED HETEROCYCLIC AZAINDANE CARBOXAMIDE CGRP RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP11796211

TETRAHYDROQUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61P 25/00, C07D 215/00, C07D 215/48, C07D 401/06, C07D 401/14, C07D 405/14, C07D 471/04, A61K 31/4725
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP12752786

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A01N 43/06, A61K 31/38
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12777344

AMIDATION PROCESS

IPC classification:
C07C 231/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP11816846

POSITIVE ALLOSTERIC MODULATORS OF MGLUR2

IPC classification:
C07D 235/26, C07D 401/04, C07D 401/06, C07D 401/10, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/10, C07D 405/06, C07D 405/10, C07D 409/10, C07D 413/10, C07D 417/14, C07D 453/02, C07D 471/04, C07D 513/14, A01N 43/50, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP12767839

C5-C6 OXACYCLIC-FUSED THIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 285/00, A61K 31/54
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12771100

5-SUBSTITUTED IMINOTHIAZINES AND THEIR MONO-AND DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61P 25/16, A61P 25/28, C07D 279/12, C07D 417/04, C07D 417/12, C07D 417/14, A61K 31/54, A61K 31/541
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12779437

AMINOMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES

IPC classification:
A01N 43/64, A01N 43/82, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11787178

NAPHTHALENE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61P 25/04, A61P 25/20, A61P 25/28, A61K 31/16
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP12789446

ARYLOXYMETHYL CYCLOPROPANE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
A61K 31/444
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13163216

Heterocyclic aspartyl protease inhibitors

IPC classification:
A61P 25/28, C07D 239/20, C07D 401/04, C07D 401/10, C07D 403/04, C07D 405/04, C07D 409/14, C07D 411/04, C07D 417/04, C07D 417/14, C07D 495/20, A61K 31/513
Applicant:
Merck & Co. Inc.
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP12811318

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

IPC classification:
C07D 471/02, A01N 43/90, A61K 31/404
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12825781

2-SPIRO-SUBSTITUTED IMINOTHIAZINES AND THEIR MONO-AND DIOXIDES AS BACE INHIBITORS, COMPOSITIONS AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12748815

INHIBITING TRANSIENT RECEPTOR POTENTIAL ION CHANNEL TRPA1

IPC classification:
A61P 25/04, C07D 473/08, A61K 31/52
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12831151

COMPOSITIONS AND METHODS FOR TREATING CANCER

IPC classification:
A01N 43/54
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12746994

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

IPC classification:
A61P 3/10, A61P 19/00, A61P 19/10, C07C 317/32, A61K 31/165
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12838891

TRIAZOLYL PDE10 INHIBITORS

IPC classification:
A01N 43/38
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12776679

PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST

IPC classification:
C07D 249/06, C07D 413/04, C07D 413/14, A01N 43/62, A61K 31/55
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12842119

2,5-DISUBSTITUTED THIOMORPHOLINE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/00
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12780370

2-PYRIDYLOXY-4-NITRILE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/00, A61P 25/20, C07D 401/14, C07D 409/14, C07D 413/14, C07D 417/14, A61K 31/4545
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12767320

PYRROLIDINE-FUSED THIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61P 25/00, C07D 513/04, A61K 31/452
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12844222

MACROCYCLES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12844517

PIPERIDINYL ALKYNE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4545
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12843886

ISOXAZOLOPYRIDINE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12843484

PARI-MUTUEL PREDICTION MARKETS AND THEIR USES

IPC classification:
G06Q 40/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12760589

PIPERIDINONE CARBOXAMIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS

IPC classification:
C07D 487/10, A61K 31/444
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12846357

NANO-SUSPENSION PROCESS

IPC classification:
A61K 9/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12845486

GAMMA SECRETASE MODULATORS

IPC classification:
A01N 43/00
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12768236

GAMMA SECRETASE INHIBITORS

IPC classification:
A01N 43/16, A61K 31/35
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11810195

BIFUNCTIONAL RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE

IPC classification:
A61K 51/00, A61M 36/14
Agent:
Andrea Schüssler, Huber & Schüssler
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11836911

ISOINDOLINONE PDE10 INHIBITORS

IPC classification:
A61P 25/18, A61P 25/22, A61P 25/28, C07D 403/06, C07D 413/14, C07D 417/14, C07D 471/04, C07D 519/00, A61K 31/44, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP12846579

QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13002486

Compositions and methods for treating epithelial and retinal tissue diseases

IPC classification:
A61K 31/70
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12850024

TRIAZOLOPYRIDINONE PDE10 INHIBITORS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12843015

BENZOXAZOLINONE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
C07D 263/54, A61K 31/423
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12784890

N-LINKED LACTAM M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
C07D 209/64, C07D 401/06, C07D 401/08, C07D 401/14, C07D 403/06, C07D 403/08, C07D 405/14, C07D 417/08, C07D 471/04, C07D 487/08, C07D 491/10, A01N 43/38, A61K 31/40, A61K 31/405
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12860596

SUBSTITUTED PIPERIDINES AS HDM2 INHIBITORS

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12779844

CYCLOHEXENE BENZOTRIAZOLE DERIVATIVES

IPC classification:
C07D 249/18, C07D 401/04, C07D 403/08, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12785978

N-METHYL TETRAHYDROQUINOLINE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61P 25/18, A61P 25/28, C07D 471/04, A61K 31/517
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12760168

PIPERIDINE CARBOXAMIDE SPIROHYDANTOIN CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/06, C07D 487/10, A61K 31/445
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12786166

N-LINKED QUINOLINEAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61P 25/28, C07D 401/06, C07D 401/14, C07D 403/12, C07D 405/14, A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12779455

ALKYNE BENZOTRIAZOLE DERIVATIVES

IPC classification:
A61P 25/18, C07D 249/18, C07D 401/06, C07D 403/06, A61K 31/4192
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12817088

FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS

IPC classification:
C07D 487/14, C07D 519/00, A01N 43/90, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12801127

IMIDAZOPYRIDIN-2-ONE DERIVATIVES

IPC classification:
C07D 471/04, C07D 513/04, C07D 519/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP14185954

Piperidinone carboxamide azaindane CGRP receptor antagonists

IPC classification:
A61P 9/08, C07D 471/10, A61K 31/437, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12826375

PYRIMIDINE PDE10 INHIBITORS

IPC classification:
A61P 25/18, C07D 401/12, C07D 401/14, C07D 405/14, C07D 417/14, C07D 487/04, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12823924

SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
C07D 263/58, C07D 277/60, C07D 277/82, C07D 413/04, C07D 417/04, A61K 31/42
Applicant:
Merck & Co. Inc.
Applicant:
Alectos Therapeutics Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13761100

BIS-QUARTERNARY CINCHONA ALKALOID SALTS AS ASYMMETRIC PHASE TRANSFER CATALYSTS

IPC classification:
C07D 453/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12779601

HYDROXYMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES

IPC classification:
C07D 249/18, C07D 401/04, C07D 405/04, A01N 43/64, A61K 31/4192
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12829393

GAMMA SECRETASE INHIBITORS

IPC classification:
A61P 25/28, C07D 493/00, A01N 43/16, A61K 31/35
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13769724

1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS

IPC classification:
A61P 31/04, C07D 471/08, A61K 31/439
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13769389

ISOXAZOLE beta-LACTAMASE INHIBITORS

IPC classification:
A61P 31/00, C07D 451/06, A61K 31/46
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13769291

PREDICTIVE BIOMARKER USEFUL FOR CANCER THERAPY MEDIATED BY A CDK INHIBITOR

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13769216

THROMBIN INHIBITORS

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13768805

IMIDAZOLYL METHYL PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS

IPC classification:
C07D 471/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12844405

NOVEL COMPOUNDS THAT ARE ERK INHIBITORS

IPC classification:
A61K 9/66
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12838133

1,3-SUBSTITUTED AZETIDINE PDE10 INHIBITORS

IPC classification:
A61P 25/18, A61P 25/22, C07D 401/14, C07D 403/14, C07D 405/14, C07D 413/14, C07D 417/14, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13788440

PYRIDINE CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13787989

PERMEABLE GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
C07D 513/04
Applicant:
Merck & Co. Inc.
Applicant:
Alectos Therapeutics Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13788382

HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13788454

PROCESS FOR THE PREPARATION OF AN INTERMEDIATE FOR AN OREXIN RECEPTOR ANTAGONIST

IPC classification:
C12P 17/16
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13788254

SPIROLACTAM CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4523
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP13787557

PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/90, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13796299

ISOTOPICALLY LABELED BIARYL UREA COMPOUNDS

IPC classification:
C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13794383

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

IPC classification:
A01N 47/28, A61K 31/17
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13748245

HCV NS3 PROTEASE INHIBITORS

IPC classification:
A61P 1/16, A61P 31/14, C07D 491/107, A61K 31/343, A61K 31/407
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13825992

alpha7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF-I

IPC classification:
C07C 311/08, C07C 311/37, C07C 311/48, C07C 311/49, C07D 213/74, C07D 231/38, C07D 237/20, C07D 239/42, C07D 239/47, C07D 241/20, C07D 261/14, C07D 277/42, A61K 31/18, A61K 31/415
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP13842584

SUBSTITUTED CYCLOPROPYL COMPOUNDS

IPC classification:
A61P 3/10, C07D 401/04, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13845052

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
C07D 231/02, A61K 31/415, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP13845875

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/44, A61K 31/505
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP11833157

METHOD FOR TREATING CYSTIC FIBROSIS WITH INHALED DENUFOSOL

IPC classification:
A61P 11/00, A61K 31/7072
Agent:
Andrea Schüssler, Huber & Schüssler
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13849733

N-SUBSTITUTED INDAZOLE SULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
A61K 31/416
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP13849421

BENZOXAZOLINONE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
C07D 263/54, A61K 31/423
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13848863

2-PYRIDYLOXY-3-SUBSTITUTED-4-NITRILE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61P 3/04, C07D 401/14, C07D 409/14, A61K 31/551
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP15159929

Pyranyl aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators

IPC classification:
A61P 25/28, C07D 401/14, C07D 405/04, C07D 405/14, C07D 417/14, C07D 471/04, C07D 491/04, A61K 31/517
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11813019

METHOD FOR TREATING OPHTHALMIC DISEASES USING KINASE INHIBITOR COMPOUNDS IN PRODRUG FORMS

IPC classification:
A01N 43/34
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Andrea Schüssler, Huber & Schüssler
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13854994

PROCESS FOR MAKING AGGLOMERATES USING ACOUSTIC MIXING TECHNOLOGY

IPC classification:
A61K 9/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP13854671

CYCLOBUTYL BENZIMIDAZOLES AS PDE10 INHIBITORS

IPC classification:
A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13855525

CYCLOPROPYL IMIDAZOPYRIDINE PDE10 INHIBITORS

IPC classification:
A61K 31/4188
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP13855567

SECONDARY ALCOHOL SUBSITUTED TRIAZOLES AS PDE10 INHIBITORS

IPC classification:
A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP13856456

PYRIMIDINE PDE10 INHIBITORS

IPC classification:
C07D 239/34
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP13856512

SUBSTITUTED PYRIDONE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
A61K 31/444
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13857755

2-PYRIDYLAMINO-4-NITRILE-PIPERIDINYL OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/445
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13811726

METHODS OF TREATING DIABETES BY ADMINISTERING A GLUCAGON RECEPTOR ANTAGONIST IN COMBINATION WITH A CHOLESTEROL ABSORPTION INHIBITOR

IPC classification:
A61P 3/10, A61K 31/397, A61K 31/404, A61K 31/415, A61K 31/435, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13862850

BACE INHIBITORS OF IMINOTHIADIAZINE DIOXIDES

IPC classification:
A61P 25/28, C07D 285/18, A61K 31/549
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13865833

NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF TREATMENT

IPC classification:
C07D 401/14
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13864999

NOVEL GLUCOKINASE ACTIVATOR COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF TREATMENT

IPC classification:
C07F 9/32
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13868947

GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
A61P 11/02, C07D 513/04
Applicant:
Merck & Co. Inc.
Applicant:
Alectos Therapeutics Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13866141

2-PYRIDYLOXY-4-ESTER OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/20, C07D 401/14, A61K 31/4545
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13865601

2-PYRIDYLOXY-3-NITRILE-4-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS

IPC classification:
C07D 401/14, C07D 413/00, C07D 413/02, A61K 31/4192
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13864049

3-ESTER-4-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS

IPC classification:
C07D 401/14, C07D 413/00, C07D 413/02, A61K 31/4192
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13864070

C5-SPIRO IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
A61K 31/497, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13865620

C5, C6 OXACYCLIC-FUSED IMINOTHIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS

IPC classification:
C07D 279/12, A61K 31/54
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13864272

C6-AZASPIRO IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
C07D 285/00, A01N 43/836, A61K 31/54, A61K 31/549
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13867977

PIPERAZINE-SUBSTITUTED [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

IPC classification:
A61K 31/4985, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP13866588

HETEROBICYCLO-SUBSTITUTED-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

IPC classification:
A61P 25/16, C07D 487/04, A61K 31/4985, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14740325

4-FLUOROPIPERIDINE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/445, A61K 31/4523
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14741091

INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL

IPC classification:
C07D 473/08
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14743190

BTK INHIBITORS

IPC classification:
C07D 213/75
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14743619

BTK INHIBITORS

IPC classification:
C07D 253/06, C07D 487/04, C07D 519/00, A61K 31/519, A61K 31/52
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14749562

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A01N 43/42, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14748737

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A01N 43/00, A61K 31/397
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14760677

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14759654

2-PYRIDYLOXY-4-ETHER OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4545
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14761162

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP14761134

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP14760553

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
The patent has been granted
EP14770245

S-IMINO-S-OXO IMINOTHIADIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 285/00, A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14770391

S-IMINO-S-OXO IMINOTHIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14768510

SUBSTITUTED PYRIDIZINONE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
C07D 237/02, A61K 31/501
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14767603

C2-AZASPIRO IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
A61P 25/28, C07D 417/04, A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14775102

ADAPTED LEPIDOPTERAN INSECT CELLS FOR THE PRODUCTION OF RECOMBINANT PROTEINS

IPC classification:
C12N 5/10
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14770224

CRYSTALLINE FORM OF A BETA-LACTAMASE INHIBITOR

IPC classification:
C07D 487/04, C07F 1/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP11836941

LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 495/04, A01N 43/12, A61K 31/38
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP14787746

HALO AND TRIFLUOROMETHYL SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14788669

HYDROXY-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14788108

2-HYDROXYMETHYL-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14787452

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF - III

IPC classification:
A61P 25/28, A61P 29/00, C07D 401/12, C07D 401/14, C07D 403/12, A61K 31/4427, A61K 31/506
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP11796210

HETEROCYCLIC FUSED PHENANTHROLINONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
C07D 471/04, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11836907

PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST

IPC classification:
C07D 401/14, A01N 31/14, A61K 31/075
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14725702

SLC2A TRANSPORTER INHIBITORS

IPC classification:
A61P 3/00, A61P 25/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 471/04, C07D 487/04, C07D 519/00, A61K 31/437, A61K 31/4985
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Jeffrey Nicholas Daniels, Page White & Farrer
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14810345

PREPARATION OF TERT-BUTYL 4-((1R,2S,5R)-6- (BENZYLOXY)-7-0X0-1,6-DIAZABICYCL0[3.2.I]OCTANE-2- CARBOXAMIDO)PIPERIDINE-1-CARBOXYLATE

IPC classification:
C07D 211/00, C07D 491/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP11841458

CLICK PEN APPLICATOR DEVICE AND METHOD OF USING SAME

IPC classification:
A61M 5/20
Applicant:
Bayer Consumer Care AG
Applicant:
Bayer Consumer Care Holdings LLC
Applicant:
MSD Consumer Care, Inc.
Agent:
Bayer Intellectual Property GmbH
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP11836924

THERAPEUTIC SOLUTION CONCENTRATE

IPC classification:
A61K 9/08, A61K 31/77
Applicant:
Bayer Consumer Care AG
Applicant:
Bayer Consumer Care Holdings LLC
Applicant:
MSD Consumer Care, Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Agent:
Bayer Intellectual Property GmbH
Status:
GRANT OF PATENT INTENDED
EP14814205

DENGUE VIRUS VACCINE COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 39/12, A61K 39/193
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP11775468

HETEROCYCLIC QUINOLIZINE DERIVED M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61P 25/28, C07D 471/14, A61K 31/47
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14823386

SUBSTITUTED AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES (IRAK-4)

IPC classification:
C07D 487/04, A61K 31/497, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP11775467

SUBSTITUTED 1,3-BENZOTHIAZOL-2(3H)-ONES AND [1,3]THIAZOLO[5,4-B]PYRIDIN-2(1H)-ONES AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2

IPC classification:
C07D 277/68, C07D 411/12, C07D 417/04, C07D 417/14, C07D 513/04, A61K 31/428, A61K 31/437
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12741504

POSITIVE ALLOSTERIC MODULATORS OF THE ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AND USES THEREOF.

IPC classification:
A61P 25/00, A61P 25/14, A61P 25/16, A61P 25/18, A61P 25/22, A61P 25/24, A61P 25/28, C07C 233/57, C07C 233/60, C07D 213/81, C07D 213/82, C07D 231/40, C07D 277/46, C07D 317/58, A61K 31/167, A61K 31/36, A61K 31/415, A61K 31/426, A61K 31/44, A61K 31/4409
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11787987

PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61P 9/08, C07D 471/10, A61K 31/437, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11852164

FUSED HETEROCYCLIC INDANE CARBOXAMIDE AS CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/06, C07D 471/04, C07D 487/04, A61K 31/015, A61K 31/437, A61K 31/522
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP14833751

OXAZOLE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
C07D 413/04, A61K 31/422, A61K 31/4525, A61K 31/454
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14834750

THIAZOLE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
C07D 413/04, A61K 31/422, A61K 31/4525, A61K 31/454
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP11801342

ISOINDOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61P 29/00, C07D 209/62, C07D 209/64, C07D 401/06, C07D 401/10, C07D 401/14, C07D 405/04, C07D 405/14, C07D 471/04, A61K 31/4035
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck Sharp & Dohme Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14836140

METHODS AND COMPOSITIONS FOR CO-EXPRESSION OF POLYPEPTIDES OF INTEREST AND IL6

IPC classification:
C12N 5/02, C12N 5/07, C12N 15/00, C12N 15/87
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP15197990

IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07B 59/00, C07D 285/18, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/12, C07D 417/04, C07D 417/12, C07D 417/14, C07D 471/04, C07D 495/04, A61K 31/54
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14837218

TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND DINACICLIB

IPC classification:
C07K 14/475, C07K 16/00, A01N 43/90, A61K 39/395
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14837215

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A01N 43/52, A01N 43/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14761460

MODULATION OF TUMOR IMMUNITY

IPC classification:
A61P 35/00, C07K 16/28, A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14840648

2,2-DIFLUORODIOXOLO A2A RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/58, A01N 43/60
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP11840630

N-Piperidinone-indane carboxamides as CGRP receptor antagonists

IPC classification:
C07D 471/04, C07D 487/04, A61K 31/40, A61K 31/445, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP14844006

C5-SPIRO IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14845934

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

IPC classification:
A61P 29/00, A61K 31/17, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14854507

METHOD OF OBTAINING THERMOSTABLE DRIED VACCINE FORMULATIONS

IPC classification:
A61K 39/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14854498

THERMOSTABLE RESPIRATORY SYNCTIAL VIRUS (RSV) VACCINE COMPOSITIONS

IPC classification:
A61P 31/14, A61K 9/19, A61K 39/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14854464

METHOD OF MICROWAVE VACUUM DRYING SPHERICAL-SHAPED PELLETS OF BIOLOGICAL MATERIALS

IPC classification:
C07K 1/36
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP11840448

SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
C07D 513/04, C07H 9/06, A61K 31/7056
Applicant:
Merck & Co. Inc.
Applicant:
Alectos Therapeutics Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP14856821

GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF USE

IPC classification:
A61P 3/10, C07D 209/18, A61K 31/404
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14861985

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
C07D 231/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP11831337

DIHYDROBENZOQUINAZOLINONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61P 25/18, A61P 25/28, C07D 401/06, C07D 401/10, C07D 401/14, C07D 405/14, A61K 31/517
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14866477

BICYCLOAMINE-SUBSTITUTED-N-BENZENESULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP11751134

POSITIVE ALLOSTERIC MODULATORS OF MGLUR2

IPC classification:
A01N 43/82
Applicant:
Merck & Co. Inc.
Agent:
Gavin MacNicol Buchan, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14870360

IMMUNOHISTOCHEMICAL PROXIMITY ASSAY FOR PD-1 POSITIVE CELLS AND PD-LIGAND POSITIVE CELLS IN TUMOR TISSUE

IPC classification:
A61P 35/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14871886

IMINOTHIADIAZEPANE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14870699

BTK INHIBITORS

IPC classification:
A61P 3/10, A61P 19/02, A61K 31/437
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14872269

BTK INHIBITORS

IPC classification:
A61P 3/10, A61P 19/02, A61K 31/437
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14872471

C-6 SPIROCARBOCYCLIC IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 285/15
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14870931

NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTAGONISTS

IPC classification:
C07D 307/91, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14872286

IFN-GAMMA GENE SIGNATURE BIOMARKERS OF TUMOR RESPONSE TO PD-1 ANTAGONISTS

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14872578

MEDIA MILLING PROCESS FOR THE MANUFACTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS IN PROPELLANTS

IPC classification:
A61J 3/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14873215

PYRIMIDONE CARBOXAMIDE COMPOUNDS AS PDE2 INHIBITORS

IPC classification:
A61P 25/18, A61P 25/22, A61P 25/28, C07D 239/36, C07D 401/12, C07D 401/14, C07D 405/12, C07D 405/14, A61K 31/513
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15740828

METALLO-BETA-LACTAMASE INHIBITORS

IPC classification:
C07D 257/04, A61K 31/41, A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15746725

NOVEL DISINTEGRATION SYSTEMS FOR PHARMACEUTICAL DOSAGE FORMS

IPC classification:
A61K 9/20
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15746174

PHARMACEUTICAL COMPOSITION OF SELECTIVE HCV NS3/4A INHIBITORS

IPC classification:
A61P 31/12, A61K 31/498
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15746768

TABLET FORMULATION FOR CGRP-ACTIVE COMPOUNDS

IPC classification:
C07D 221/02, A61K 9/26, A61K 31/437
Applicant:
Merck & Co. Inc.
Agent:
Hoffmann Eitle PartmbB
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15746312

ANTIBODIES THAT BIND TO HUMAN TAU AND ASSAY FOR QUANTIFYING HUMAN TAU USING THE ANTIBODIES

IPC classification:
C07K 16/18, A61K 39/395
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15759159

HIV PROTEASE INHIBITORS

IPC classification:
A61K 31/5377
Applicant:
Merck & Co. Inc.
Applicant:
Merck Canada Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15760695

PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS

IPC classification:
C07D 241/36, C07D 281/10
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15761797

PURIFYING INSULIN USING CATION EXCHANGE AND REVERSE PHASE CHROMATOGRAPHY IN THE PRESENCE OF AN ORGANIC MODIFIER AND ELEVATED TEMPERATURE

IPC classification:
C07K 1/00, A61K 38/00, A61K 38/28
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15715934

4'-SUBSTITUTED NUCLEOSIDE-DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61P 1/16, C07D 487/04, C07H 19/06, C07H 19/14, A61K 31/7064, A61K 31/7076
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15773458

PHOSPHATE BASED LINKERS FOR INTRACELLULAR DELIVERY OF DRUG CONJUGATES

IPC classification:
A61K 47/24
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15774282

PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61K 31/501, A61K 31/506, A61K 31/513
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15779184

FACTOR IXA INHIBITORS

IPC classification:
C07D 207/02, C07D 261/20, C07D 413/14
Applicant:
Merck & Co. Inc.
Applicant:
Mochida Pharmaceutical Co Ltd
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15780578

FACTOR IXA INHIBITORS

IPC classification:
C07D 207/02, C07D 261/20, C07D 413/14
Applicant:
Merck & Co. Inc.
Applicant:
Mochida Pharmaceutical Co Ltd
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15782608

PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST

IPC classification:
C07D 413/14, A61K 31/423, A61K 31/551
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15783339

FACTOR XIa INHIBITORS

IPC classification:
C07D 471/10, C07D 498/20, A61K 31/438
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15789928

BETA-TETRAZOLYL-PROPIONIC ACIDS AS METALLO-BETA-LACTAMASE INHIBITORS

IPC classification:
A61K 31/192, A61K 31/41
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15800524

FACTOR XIA INHIBITORS

IPC classification:
A61K 31/167, A61K 31/4192, A61K 31/44
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15803641

C2-CARBOCYCLIC IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 417/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature